Human placenta derived 3D mesenchymal stem cells

人胎盘来源3D间充质干细胞

Report date: 2026/04/28 20:00:22

Base Information

Drug NameHuman placenta derived 3D mesenchymal stem cells
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsIschemic StrokeStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesGuojian Qingke Biomedical Technology (Beijing) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGuojian Qingke Biomedical Technology (Beijing) Co Ltd
Inactive CompaniesN/A
Active IndicationsIschemic StrokeStroke
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A